Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Trioxaquine PA1259 alkylates heme in the blood-feeding parasite Schistosoma mansoni.

Pradines V, Portela J, Boissier J, Coslédan F, Meunier B, Robert A.

Antimicrob Agents Chemother. 2011 May;55(5):2403-5. doi: 10.1128/AAC.00082-11. Epub 2011 Feb 7.

2.

The antimalarial trioxaquine DU1301 alkylates heme in malaria-infected mice.

Bousejra-El Garah F, Claparols C, Benoit-Vical F, Meunier B, Robert A.

Antimicrob Agents Chemother. 2008 Aug;52(8):2966-9. doi: 10.1128/AAC.00165-08. Epub 2008 Jun 16.

3.

Antischistosomal activity of trioxaquines: in vivo efficacy and mechanism of action on Schistosoma mansoni.

Portela J, Boissier J, Gourbal B, Pradines V, Collière V, Coslédan F, Meunier B, Robert A.

PLoS Negl Trop Dis. 2012;6(2):e1474. doi: 10.1371/journal.pntd.0001474. Epub 2012 Feb 14.

4.

Inhibition of heme aggregation by chloroquine reduces Schistosoma mansoni infection.

Oliveira MF, d'Avila JC, Tempone AJ, Soares JB, Rumjanek FD, Ferreira-Pereira A, Ferreira ST, Oliveira PL.

J Infect Dis. 2004 Aug 15;190(4):843-52. Epub 2004 Jul 20.

5.

Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.

Liang YS, Coles GC, Dai JR, Zhu YC, Doenhoff MJ.

J Helminthol. 2002 Dec;76(4):327-33.

PMID:
12498638
6.

Schistosomula, pre-adults and adults of Schistosoma mansoni ingest fluorescence-labelled albumin in vitro and in vivo: implication for a drug-targeting model.

Holtfreter MC, Loebermann M, Frei E, Riebold D, Wolff D, Hartung G, Kinzelbach R, Reisinger EC.

Parasitology. 2010 Sep;137(11):1645-52. doi: 10.1017/S0031182010000405. Epub 2010 May 26.

PMID:
20500919
7.
8.

Biological characteristics of praziquantel-resistant and -susceptible isolates of Schistosoma mansoni.

Liang YS, Coles GC, Dai JR, Zhu YC, Doenhoff MJ.

Ann Trop Med Parasitol. 2001 Oct;95(7):715-23.

PMID:
11784425
9.

Interference with hemozoin formation represents an important mechanism of schistosomicidal action of antimalarial quinoline methanols.

Corrêa Soares JB, Menezes D, Vannier-Santos MA, Ferreira-Pereira A, Almeida GT, Venancio TM, Verjovski-Almeida S, Zishiri VK, Kuter D, Hunter R, Egan TJ, Oliveira MF.

PLoS Negl Trop Dis. 2009 Jul 14;3(7):e477. doi: 10.1371/journal.pntd.0000477.

10.

Influence of parasite strain on chemotherapy of murine infections with Schistosoma mansoni.

Lee HG, Cheever AW, Fairweather WR.

Bull World Health Organ. 1971;45(2):147-55.

11.

Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges.

Abdul-Ghani R, Loutfy N, el-Sahn A, Hassan A.

Parasitol Res. 2009 Apr;104(5):955-65. doi: 10.1007/s00436-009-1371-7. Epub 2009 Mar 3. Review.

PMID:
19255786
12.

Heme as trigger and target for trioxane-containing antimalarial drugs.

Meunier B, Robert A.

Acc Chem Res. 2010 Nov 16;43(11):1444-51. doi: 10.1021/ar100070k. Epub 2010 Aug 30. Review.

PMID:
20804120
13.

Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni.

Manneck T, Haggenmüller Y, Keiser J.

Parasitology. 2010 Jan;137(1):85-98. doi: 10.1017/S0031182009990965. Epub 2009 Oct 9.

PMID:
19814844
14.

Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice.

Li HJ, Wang W, Qu GL, Li YZ, Tao YH, Xing YT, Wang XT, Dai Y, Wei JY, Dai JR, Coles GC, Liang YS.

Parasitol Res. 2012 May;110(5):1727-32. doi: 10.1007/s00436-011-2692-x. Epub 2011 Oct 18.

PMID:
22006193
15.

In vivo activity of aryl ozonides against Schistosoma species.

Keiser J, Ingram K, Vargas M, Chollet J, Wang X, Dong Y, Vennerstrom JL.

Antimicrob Agents Chemother. 2012 Feb;56(2):1090-2. doi: 10.1128/AAC.05371-11. Epub 2011 Nov 21.

16.

Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel.

William S, Sabra A, Ramzy F, Mousa M, Demerdash Z, Bennett JL, Day TA, Botros S.

Int J Parasitol. 2001 Aug;31(10):1093-100.

PMID:
11429173
17.

Sensibility of different larval stages of Schistosoma mansoni to the larvae disappearing reaction (LDR) in murine schistosomiasis (1).

de Melo AL, Pereira LH, Chamone M.

Rev Inst Med Trop Sao Paulo. 1986 Nov-Dec;28(6):395-9. No abstract available.

PMID:
3110909
18.

Drug resistance or tolerance in schistosomes?

Coles GC.

Trends Parasitol. 2002 Jul;18(7):294. No abstract available.

PMID:
12379947
19.

Resistance of Schistosoma mansoni to praziquantel: is there a problem?

Doenhoff MJ, Kusel JR, Coles GC, Cioli D.

Trans R Soc Trop Med Hyg. 2002 Sep-Oct;96(5):465-9. Review.

PMID:
12474468
20.

Drug-metabolizing enzymes and praziquantel bioavailability in mice harboring Schistosoma mansoni isolates of different drug susceptibilities.

Botros SS, El-Din SH, El-Lakkany NM, Sabra AN, Ebeid FA.

J Parasitol. 2006 Dec;92(6):1344-9.

PMID:
17304818
Items per page

Supplemental Content

Write to the Help Desk